Invention Grant
- Patent Title: Monoclonal antibody directed against CXCR5
- Patent Title (中): 针对CXCR5的单克隆抗体
-
Application No.: US14787478Application Date: 2014-04-30
-
Publication No.: US09534054B2Publication Date: 2017-01-03
- Inventor: Christine Power , Olivier Leger , Paul Bradfield , Horacio G. Nastri , Christel Iffland , Qi An
- Applicant: ARES TRADING S.A.
- Applicant Address: CH Aubonne
- Assignee: ARES TRADING S.A.
- Current Assignee: ARES TRADING S.A.
- Current Assignee Address: CH Aubonne
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP13166251 20130502
- International Application: PCT/EP2014/058903 WO 20140430
- International Announcement: WO2014/177652 WO 20141106
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; A61K51/10 ; C07K16/28
Abstract:
The invention relates to monoclonal antibodies against human CXCR5 and to their use in the treatment of autoimmune or inflammatory diseases, as well as cancers.
Public/Granted literature
- US20160115235A1 MONOCLONAL ANTIBODY DIRECTED AGAINST CXCR5 Public/Granted day:2016-04-28
Information query
